Published on
July 21, 2020
- 11:30 GMT
Biogen Plans to Initiate Phase 4 Study Evaluating Benefit of SPINRAZA® (nusinersen) in Patients Treated with Zolgensma® (...
In the long-term follow-up study of Zolgensma® and real-world experience, it has been reported that some patients previously treated with gene therapy have been treated with SPINRAZA1,2,3 The RESPOND study aims to evaluate the efficacy and safety of …
Distribution channels:
Media, Advertising & PR, Technology
...
